Real-time enrollment status for this inflammatory bowel disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:53 PM UTC
| NCT Number | NCT04844606 |
| Recruiting Status | Recruiting |
| Condition | Inflammatory Bowel Disease |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT04844606 is currently recruiting participants. This phase3 study for inflammatory bowel disease is actively seeking new participants at 11 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04844606 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04844606 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.